Filing Details
- Accession Number:
- 0001181431-10-053620
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-04 21:16:25
- Reporting Period:
- 2010-11-02
- Filing Date:
- 2010-11-04
- Accepted Time:
- 2010-11-04 21:16:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891288 | Questcor Pharmaceuticals Inc | QCOR | Pharmaceutical Preparations (2834) | 330476164 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1378166 | David Young | 8850 Stanford Blvd. Suite 2500 Columbia MD 21045 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-02 | 3,750 | $0.43 | 12,047 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-11-02 | 10,000 | $0.87 | 22,047 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-11-02 | 14,375 | $1.47 | 36,422 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-02 | 28,125 | $12.33 | 8,297 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | STOCK OPTION EXERCISE (Right to Buy) | Disposition | 2010-11-02 | 3,750 | $0.00 | 3,750 | $0.43 |
| Common Stock | STOCK OPTION EXERCISE (Right to Buy) | Disposition | 2010-11-02 | 10,000 | $0.00 | 10,000 | $0.87 |
| Common Stock | STOCK OPTION EXERCISE (Right to Buy) | Disposition | 2010-11-02 | 14,375 | $0.00 | 14,375 | $1.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-07-15 | No | 4 | M | Direct | |
| 0 | 2017-05-10 | No | 4 | M | Direct | |
| 625 | 2016-12-31 | No | 4 | M | Direct |
Footnotes
- Non-Qualified Stock option granted under the Questcor Pharmaceuticals, Inc. 2004 Non-Employee Directors' Equity Incentive Plan on July 16, 2007.
- Non-Qualified Stock option granted under the Questcor Pharmaceuticals, Inc. 2004 Non-Employee Directors' Equity Incentive Plan on May 11, 2007.
- Non-Qualified Stock option granted under the Questcor Pharmaceuticals, Inc. 2004 Non-Employee Directors' Equity Incentive Plan on January 1, 2007.
- The options vested monthly over 48 months, beginning on the date of each grant.
- Options were vested 100% on date of grant.
- In addition to those shown above, Dr. Young also has vested options to purchase 165,000 shares and unvested options to purchase 275,000 shares.
Billionaire Hedge Funds
